Company Search:
Advanced Search
Sponsored Links
Oncovista Innovative Therapies, Incorporation Company Snapshot
Oncovista Innovative Therapies, Incorporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oncovista Innovative Therapies, Incorporation with three other companies in this sector in the United States: Cyclacel Pharmaceuticals, Inc. (2009 sales of $911,000.00 of which 100% was Pharmaceutical Products), MusclePharm Corp ($1.02 million ), and Newlink Genetics Corporation ($934,000.00 of which 100% was Research And Development).

Sales Analysis.
  Stock Performance Chart for Oncovista Innovative Therapies, Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2016): .07
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Oncovista Innovative Therapies, Incorporation Key Data:
  Ticker: OVIT Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2009 Sales 982,048
(Year Ending Jan 2010).
Employees: 3
  Currency: U.S. Dollars Market Cap: 1,549,680
  Fiscal Yr Ends: December Shares Outstanding: 23,558,530
  Share Type: Common Closely Held Shares: 8,035,793
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.